ArticleThe Korean journal of pain2026
Pericapsular nerve group block combined with lateral femoral cutaneous nerve block
Article in The Korean journal of pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The combination of the pericapsular nerve group (PENG) and lateral femoral cutaneous nerve (LFCN) blocks has been proposed as a motor-sparing alternative to the fascia iliaca compartment block (FICB) for analgesia after hip surgery. However, previous reviews were limited by insufficient data to draw definitive conclusions regarding this specific combination. Methods: The authors conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing PENG plus LFCN Results: Six RCTs (442 patients) were included in the analysis. PENG + LFCN significantly reduced resting pain scores at 6 hours (mean difference [MD] -0.72; 95% confidence interval [CI] -1.28 to -0.16; Conclusions: PENG plus LFCN provides superior analgesia and motor preservation compared with FICB, facilitating early ambulation and optimizing functional recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.